Plasma Fractionation Market to Worth USD 58.24 Billion by 2030 | Skyquest Technology
January 10, 2024 11:00 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Jan. 10, 2024 (GLOBE NEWSWIRE) -- According to SkyQuest, the global plasma fractionation market is experiencing robust growth, driven by several key factors. One significant...
Plasma Fractionation Market Research Report 2023: Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC - Global Forecast to 2028
November 28, 2023 10:23 ET
|
Research and Markets
Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor, PCC), Application (Neurology,...
Albumin Market Size to Surpass USD 8.76 Billion by 2030, at a CAGR of 4.7%
November 28, 2023 08:14 ET
|
Fortune Business Insights
Pune, India, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The albumin market size was valued at USD 6.14 billion in 2022 and is expected to be worth USD 6.35 billion in 2023. The market is projected to reach...
Myositis Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
November 13, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Myositis Clinical Trial Pipeline Analysis Demonstrates 20+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses...
Diabetic Nephropathy Market to Grow at a Substantial Growth Rate by 2032, Assesses DelveInsight |Key Players in the Market - Prokidney, Inversago, Palatin Technologies, Lexicon, Daiichi Sankyo, CSL Behring
November 07, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Diabetic Nephropathy Market to Grow at a Substantial Growth Rate by 2032, Assesses DelveInsight |Key Players in the Market - Prokidney, Inversago,...
uniQure Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
November 07, 2023 07:05 ET
|
uniQure Inc.
~ Announced FDA clearance of Investigational New Drug (IND) application for AMT-260 in refractory mesial temporal lobe epilepsy ~ ~ On track to provide clinical update from U.S. and European Phase...
Idiopathic Pulmonary Fibrosis Market to Show Immense Growth at a CAGR of 6.6% During the Study Period (2019–2032) | DelveInsight
October 30, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Idiopathic Pulmonary Fibrosis Market to Show Immense Growth at a CAGR of 6.6% During the Study Period (2019–2032) | DelveInsight The overall...
Rising Prevalence of Bleeding Disorders Drives Robust Growth in the Global Bleeding Disorders Treatment Market to 2028
October 23, 2023 07:58 ET
|
Research and Markets
Dublin, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The "Bleeding Disorders Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ...
Plasma Fractionation Market Size to Surpass USD 53.33 Billion by 2030, exhibiting a CAGR of 7.2%
October 23, 2023 05:38 ET
|
Fortune Business Insights
Pune, India, Oct. 23, 2023 (GLOBE NEWSWIRE) -- The global plasma fractionation market size was USD 30.64 billion in 2022, and it is projected to grow from USD 32.75 billion in 2023 to USD 53.33...
Kamada Announces Recent Achievements with CYTOGAM® including Availability of Product Manufactured by the Company for U.S Commercial Sale and Presentation of New Clinical Data
October 16, 2023 07:00 ET
|
Kamada Ltd.
Following Recent FDA Approval of Technology Transfer Process, CYTOGAM® Manufactured by Kamada at its Facility Now Available for Commercial Sales in U.S.New Clinical Data Highlighting Five-year...